Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Anand Bidarkar appointed vice-president of BD for Ecron Acunova

This article was originally published in Scrip

Dr Anand Bidarkar has been hired as vice-president of business development for the Ecron Acunova group. He has extensive functional experience in operations, business development, strategic partnerships and leading business units with multibillion dollar groups like Novartis, inVentiv and Apollo as well as with mid-sized firms like Sun Pharmaceuticals. Prior to joining EA, Dr Bidarkar was working with SIRO Clinpharm as vice-president of business development. He spearheaded alliance formation with complimentary service providers and transformed the business model of the company from being dependent on single project, single country contracts to programme level and multinational deals.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC016696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel